BioWorld

Aug. 22, 2003

IPOs On The Rise: Nitromed, Pharmion, Acusphere On File

Three biotech companies recently have filed for initial public offerings in what appears to be a developing trend. (BioWorld Today) Read More

Cephalon's Hostile Takeover Bid For CIMA Ups The Ante

Two Human Immunities - Innate, Adaptive - Set Experimental Model To Mimic Multiple Sclerosis Course

Merck Options, Returns Aspects Of Vical's DNA Delivery Platform

BioStratum Opens Bridge Funding With $9.5M For Nephropathy Drug

CuraGen Subsidiary Sequences Whole Adenovirus In One Day

Other News To Note

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026